Ito, Fumiko
Miura, Masatomo
Fujioka, Yuki
Abumiya, Maiko
Kobayashi, Takahiro
Takahashi, Saori
Yoshioka, Tomoko
Kameoka, Yoshihiro
Takahashi, Naoto http://orcid.org/0000-0002-6758-3787
Funding for this research was provided by:
JSPS KAKENHI (20K0715)
Article History
Received: 12 July 2020
Revised: 31 August 2020
Accepted: 7 September 2020
First Online: 6 October 2020
Compliance with ethical standards
:
: Dr. Naoto Takahashi reports that he has received Grants and speaker’s fees from Novartis Pharmaceuticals, speaker’s fees from Bristol Myers Squibb, Grants and speaker’s fees from Pfizer, Grants and speaker’s fees from Otsuka Pharmaceutical, Grants from Kyowa Hakko Kirin, Grants from Astellas Pharma, Grants from Chugai Pharmaceutical, Grants from Asahi Kasei Pharma, Grants from Ono Pharmaceutical, and Grants from Eisai Pharmaceuticals, outside of the submitted work. The remaining authors declare that they have no conflicts of interest.